|
American Academy of Pediatrics (AAP) Council on Genetics
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NICHD
|
The AAP Council on Genetics (COG) studies and makes recommendations to the AAP Board of Directors on recent advances in genetics and provides support to chapters on state legislative issues as they relate to genetics.
|
|
American Academy of Pediatrics (AAP) Council on Injury, Violence and Poison Prevention (COIVPP)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, HRSA, IHS
|
NICHD
|
The AAP Council on Injury, Violence, and Poison Prevention was formed on July 1, 2011, with the merging of the former Section and Committee on Injury, Violence, and Poison Prevention. This new leadership body addresses all facets of injury prevention policy, programs, advocacy, and education of general pediatricians, pediatric subspecialists, and families as a unified group.
|
|
American Academy of Pediatrics (AAP) Section on Obesity
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The Section on Obesity's mission is to improve the health and well-being of children and families by reducing the prevalence of childhood obesity and promoting healthy active living.
|
|
American College of Obstetricians and Gynecologists (ACOG) Patient Education Review Panel
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD
|
The Patient Education Review Panel (PERP) reviews the College Patient Education materials for currency, accuracy, and consistency with College guidelines.
|
|
American Community Survey (ACS) Interagency Committee Meeting
|
Meeting/ Workshop
|
ACF, AHRQ, ASPE, CDC, CMS, HRSA
|
NICHD
|
Coordinated by the U.S. Census Bureau
|
|
American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The National Institutes of Health (NIH) advises the American Congress of Obstetricians and Gynecologists (ACOG) Committee on Gynecologic Practice about research advances that can inform gynecologic clinical practice.
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NHLBI, NCATS, NIMH, NINDS
|
The Bespoke Gene Therapy Consortium (BGTC) is a developing public-private partnership dedicated to making gene therapy a reality for people with rare genetic diseases affecting populations too small to be viable from the current commercial perspective.
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NINDS, NCATS, NCI, NIAAA, NIDA
|
The mission of the Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership funded by the US Food and Drug Administration (FDA) is to identify, prioritize, sponsor, coordinate, and promote innovative activities — with a special interest in optimizing clinical trials — that will expedite the discovery and development of improved analgesic treatments for the benefit of the public health.
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
NIAID
|
In this ancillary swab study, up to 3,000 adolescent participants 12-17 years of age who participated in the Pre-fusion Protein Subunit Vaccine Efficacy Novavax Trial COVID-19 (PREVENT-19) Pediatric Expansion study and who provided informed consent/assent for the ancillary swab study were sampled twice weekly starting at the day 21 visit, or as soon as possible thereafter, of the initial injection period until the second dose of the blinded cross-over (approximately 28 weeks) with nasal swabs for detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection by reverse transcription polymerase chain reaction (RT-PCR) and incident infections tallied. Data sources from the Observational Study (e.g., study product assignment, daily symptomatology) will be used in the ancillary study to estimate the vaccine efficacy against SARS-CoV-2 infection, including asymptomatic infection or mildly symptomatic infection not meeting the Coronavirus Disease 2019 (COVID-19) primary endpoint definition for the Phase 3 study.
|
|
Animal Care Radiation Models Meeting
|
Meeting/ Workshop
|
ASPR
|
NIAID
|
The purpose of this meeting is to work with stakeholders to examine and discuss currently accepted animal care protocols and how they translate to human care in an emergency setting. The meeting will also explore how euthanasia criteria impact drug efficacy studies. A meeting report will be published as an open source of information for other researchers.
|